Results 241 to 250 of about 174,548,201 (285)

Amnioinfusion for preterm premature rupture of membranes

2011
Preterm premature rupture of membranes (PPROM) is a leading cause of perinatal morbidity and mortality. Amnioinfusion aims to restore amniotic fluid volume by infusing a solution into the uterine cavity.The objective of this review was to assess the effects of amnioinfusion for PPROM on perinatal and maternal morbidity and mortality.We searched the ...
G Justus, Hofmeyr, George, Essilfie-Appiah, Theresa A, Lawrie   +2 more
openaire   +2 more sources

Tocolytic Therapy in Preterm Premature Rupture of Membranes

Obstetrics and Gynecology Clinics of North America, 2020
"Trials evaluating tocolytic use in preterm premature rupture of membranes (PPROM) have been small and lacked adequate power to evaluate uncommon outcomes. There still is much controversy on the benefit, length of use, route, and drug of choice among clinicians treating patients with PPROM.
Hector, Mendez-Figueroa, Suneet P, Chauhan   +1 more
openaire   +2 more sources

Amnioinfusion with Preterm, Premature Rupture of Membranes

Clinics in Perinatology, 1992
Excluding labor, the greatest risks to the fetus from preterm PROM are umbilical cord accidents and infection. Heretofore, the clinical options for the PROM patient have been limited. With the advent and refinement of amnioinfusion, the utility of expectant management may be greatly increased.
openaire   +2 more sources

Expectant management of preterm premature rupture of the membranes

American Journal of Obstetrics and Gynecology, 1994
Our purpose was to (1) evaluate expectant management of preterm premature rupture of the membranes between 20 and < 36 weeks' gestation and (2) compare outcomes in service and private populations.The study included only singleton pregnancies prospectively managed between 20 and < 36 weeks' gestation with proved preterm premature rupture of the ...
L H, Nelson, R L, Anderson, T M, O'Shea, M, Swain   +3 more
openaire   +2 more sources

Antenatal Corticosteroids in Preterm Premature Rupture of Membranes

Clinical Obstetrics and Gynecology, 1998
It is clear that there is no unequivocal indication for the use of antenatal corticosteroids in the preterm gestation with PROM. Extrapolating the effects seen in gestations with intact membranes, however, there are potential benefits in reduction of neonatal respiratory disease and intracranial hemorrhage at the expense of increased risks of maternal ...
B, Chen, M K, Yancey
openaire   +2 more sources

Fetal Behavior in Preterm Premature Rupture of the Membranes

Clinics in Perinatology, 1989
Although the subject has been the focus of a large body of obstetric literature, premature rupture of the membranes and its pathogenesis, management, and incidence of sequelae remain confused and controversial. The origins of this disquieting state of affairs can be traced to the lack of a specific, narrow definition of the condition, and resultant ...
I, Goldstein, J A, Copel, J C, Hobbins
openaire   +2 more sources

Amniocentesis in the Management of Preterm Premature Rupture of the Membranes

Australian and New Zealand Journal of Obstetrics and Gynaecology, 1991
EDITORIAL COMMENT: The clinical value of amniocentesis in the management of patients with premature rupture of the membranes is not established although this investigation is widely practised in the United States of America for this indication.
J, Dudley, G, Malcolm, D, Ellwood
openaire   +2 more sources

Preterm Labor, Preterm Premature Rupture of Membranes, and Chorioamnionitis

Clinics in Perinatology, 2005
In this article, the author reviews the etiology and biochemical links between infection and preterm birth, the problem of preterm birth, and the management of infection-related risks of preterm birth. The management section reviews current opinions regarding prophylactic antibiotic therapy in the prevention of preterm birth, adjunctive antibiotic ...
openaire   +2 more sources

Antibiotic Therapy in Preterm Premature Rupture of Membranes

Clinical Obstetrics and Gynecology, 1998
Good quality evidence supports the use of antibiotic therapy in women with preterm PROM for whom expectant management is planned. The best evidence supports the choice of an extended-spectrum agent or combination administered intravenously for 2 days followed by an extended spectrum or combination of oral agents for several more days.
openaire   +2 more sources

Maturity testing with preterm premature rupture of the membranes

Clinics in Perinatology, 2001
The presence or absence of fetal pulmonary maturity as assessed by amniotic fluid analysis and the role of fetal maturity tests in the management of premature rupture of the membranes are addressed. The hazards of the high falsely immature test are carefully explored. A management scheme based on the results of amniotic fluid analysis is also described.
openaire   +2 more sources